LUCD — Lucid Diagnostics Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1799011 ·
Last close
$0.83
Market Cap
$157.72M
52W High
$1.63
52W Low
$0.75
ADV30
1,037,920
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,474,000 | 29,000 | -12,801,000 | -11,687,000 | 38,946,000 | 33,404,000 | 28,019,000 |
| Mar 2026 | 1,256,000 | -369,000 | -12,114,000 | -13,909,000 | 34,080,000 | 27,876,000 | 30,080,000 |
| Dec 2025 | 1,504,000 | -356,000 | -14,011,000 | -16,266,000 | 40,445,000 | 34,705,000 | 29,509,000 |
| Sep 2025 | 1,211,000 | -486,000 | -11,759,000 | -10,397,000 | 53,198,000 | 47,332,000 | 27,363,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-46,121,000
Investing CF
$-319,000
Financing CF
$49,078,000
CapEx
$-319,000
Dividends Paid
—
Buybacks
$-17,000
EPS Diluted TTM
$-0.45
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-297,963,000
Inventory
$469,000
Receivables
$689,000
ST Investments
—
EBIT TTM
$-44,991,000
Pretax Income TTM
$-45,011,000
Interest Exp TTM
$20,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,445,000
EBITDA
$-49,808,000
Free Cash Flow
$-26,429,124
Enterprise Value
$139,930,768
Total Cash
$34,472,000
Total Debt
$24,909,000
Shares Out
190,948,730
Trailing EPS
$-0.41
Book Value
$0.06
ROE
-556.3%
ROA
-81.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,706,000 | -49,640,000 | -58,010,000 | 40,445,000 | 29,509,000 | 10,936,000 | -46,485,000 |
| Dec 2024 | 4,346,000 | -46,052,000 | -45,529,000 | 30,715,000 | 25,324,000 | 5,391,000 | -44,140,000 |
| Dec 2023 | 2,428,000 | -48,482,000 | -52,666,000 | 27,270,000 | 29,581,000 | -2,311,000 | -32,817,000 |
| Dec 2022 | 377,000 | -56,251,000 | -56,171,000 | 32,509,000 | 9,462,000 | 23,047,000 | -29,685,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NYXH | Nyxoah SA | $147.67M | $1.45 | — |
| KRMD | KORU Medical Systems, Inc. | $147.44M | $3.21 | — |
| EBRCZ | EBR Systems, Inc. | $169.66M | $0.23 | — |
| INGN | Inogen Inc | $142.25M | $5.36 | — |
| ZJYL | Jin Medical International Ltd. | $140.70M | $1.91 | — |
News headlines (Yahoo Finance, 1h cache)
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
2026-09-22 11:55 · Yahoo
Lucid Diagnostics (LUCD) Q2 2026 Earnings Call Transcript
2026-08-20 13:58 · Yahoo
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
2026-08-14 12:00 · Yahoo
Lucid Diagnostics Inc (LUCD) (Q2 2026) Earnings Call Highlights: Strategic Pivot to High-Value ...
2026-08-13 23:06 · Yahoo
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates
2026-08-13 13:10 · Yahoo
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
2026-08-13 12:00 · Yahoo
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
2026-08-05 12:36 · Yahoo
Lucid Diagnostics to Participate in Upcoming Investor Conferences
2026-08-04 12:30 · Yahoo
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
2026-06-02 13:57 · Yahoo
Lucid Diagnostics Inc. Q2 2026 Earnings Call Summary
2026-08-14 02:07 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.